Navigation Links
Raptor Pharmaceuticals Corp. Announces Presentation at 5th International Cystinosis Conference 2008
Date:6/23/2008

tor currently has eight patent applications under review in the U.S. and abroad, as well as four provisional patent applications in the U.S. In addition, Raptor has licensed two provisional patent applications from Washington University and one patent application and one provisional patent application from UC San Diego.

For additional information, please visit http://www.raptorpharma.com.

FORWARD LOOKING STATEMENTS

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future results of operation or future financial performance, including, but not limited to the following statements: Raptor's ability to develop DR Cysteamine for the treatment of Cystinosis; Raptor's ability to formulate and manufacture DR Cysteamine in clinical quantities to support clinical trials; DR Cysteamine's ability to reduce side effects, reduce dosage and/or frequency of dosing in Cystinosis patients; and DR Cysteamine's ability to improve the quality of life of families affected by Cystinosis. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our actual results to be materially different from these forward-looking statements. Factors which may significantly change or prevent our forward looking statements from fruition include that we may be unsuccessful in developing any products or acquiring products; that our technology may not be validated as we progress further and our methods may not be accepted by the scientific community; that we are unable to retain or attract key employees whose knowledge is essential to the development of our products; that unforeseen scientific difficulties develop with our process; that our patents are not sufficient to protect essential aspects of our technology; that competitors may inven
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Raptor Pharmaceuticals Corp. To Present at BIO 2008 International Convention
2. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
3. Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline
4. Raptor Pharmaceuticals Acquires Orphan Clinical Program
5. Onyx Pharmaceuticals to Present at Jefferies 2nd Annual Healthcare Conference
6. Sunesis Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
7. Immtech Pharmaceuticals and Beijing Capital Medical University Announce Joint Venture to Provide Contract Research Services in China
8. Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
9. GANIC Pharmaceuticals Launched with Premier Pharmaceutical Industry Executives
10. Barrett Katz, MD, MBA, Named CEO of Danube Pharmaceuticals
11. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Global Stem Cells Group today announced plans ... of aesthetic medicine experts and innovators. GSCG Advisory Board ... company’s brand new training course that combines facial fat ... , The course is designed to address the primary ... facial aging caused by volume loss. , The ...
(Date:4/18/2015)... , April 18, 2015 ... CRIS ) will be presenting data at ... American Associate of Cancer Research Annual Meeting (April ...      (Logo: http://photos.prnewswire.com/prnh/20130418/608115 ) , ... proprietary Nicotinamide phosphoribosyltransferase (NAMPT) small molecule inhibitors program, ...
(Date:4/17/2015)... Reed Technology and Information Services Inc. ... and submission to the U.S. Food and Drug Administration ... Distribution Report (LDR) service for manufacturers of biologics, including ... FDA’s new rule on electronic submission of LDRs. ... and timing of particular biologics introduced to the marketplace, ...
(Date:4/17/2015)... /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD; OTCQX: SQIDF), ... and commercializes proprietary technologies and products for advanced ... received approval from the TSX Venture Exchange to ... purchase warrants ("the Warrants") of the Company, which ... 2013 private placement financing. Each Warrant ...
Breaking Biology Technology:Global Stem Cells Group to Host Featured Speaker at The Aesthetic Meeting 2015 in Montreal 2Global Stem Cells Group to Host Featured Speaker at The Aesthetic Meeting 2015 in Montreal 3Aurigene to Present its NAMPT and IRAK-4 Inhibitors Programs at AACR 2015 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 3SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3
... nanostructures that scatter and channel light, University of ... thin-film single junction solar cells with the potential ... UC San Diego effort to break the theoretical ... junction cells recently received a big funding boost ...
... Stock Exchange Symbol: MS, EDMONTON, May 15 /PRNewswire-FirstCall/ ... the treatment of multiple sclerosis (MS), today,announced financial and ... BioMS, in partnership with Eli Lilly and Company, is,developing ... for,the treatment of MS undergoing pivotal trials in Canada, ...
... in 90 percent ... of ... technology leader for treating precancerous conditions of the,digestive tract, today announced ... free of the highest-risk of Barrett,s,esophagus after having a non-surgical, endoscopic ...
Cached Biology Technology:UC San Diego nanostructures will raise thin-film solar cell efficiency 2BioMS Medical announces first quarter 2008 results 2BioMS Medical announces first quarter 2008 results 3BioMS Medical announces first quarter 2008 results 4BioMS Medical announces first quarter 2008 results 5New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus 2New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus 3
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
(Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has ... Global Strategic Business Report" report to their offering. ... in US$ Thousands by the following Segments: Face Biometrics, and Voice ... Canada , Japan , ... East & Africa , and ...
(Date:3/23/2015)...   HOYOS Labs , a leading global authentication ... the Company will demonstrate multiple biometrics-based technologies under its ... Connect:ID on March 23 through 25, 2015, in ... the IEEE Biometric Open Protocol Standard; free biometrics-based consumer ... control system. BOPS was invented by HOYOS Labs and ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... Baylor University, in collaboration with the U.S Forest Service ... predicts the risk of wetland habitat loss based on local ... The new model was used to predict the fate of ... States and was published in the journal Ecological Applications ...
... Scientists from the University of Sheffield have developed ... anti-counterfeit devices on passports or banknotes due to their ... use pigments but instead exhibit intense colour due to ... for beetle shells and butterfly wings. These colours ...
... Genome Institute of Singapore (GIS) of the Agency for ... involved in controlling genes work together to carry out ... very first time, how they can change interaction partners ... highlighted the collaborative nature of modern biology in which ...
Cached Biology News:New study predicts risk of wetland habitat loss in southern United States 2New study predicts risk of wetland habitat loss in southern United States 3Rainbows without pigments offer new defense against fraud 2Scientists discover switch to speed up stem cell production 2Scientists discover switch to speed up stem cell production 3
Animal Origin Free...
IHC Detection Kit (Broad Spectrum AEC)....
...
... ,,GenScript offers many antibody modification ... fragmentation. Labeling antibodies with biotin and ... quantitation of the target molecule. In ... use only the antigen-binding (Fab) portion ...
Biology Products: